Government of Oman Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2015
NCT02525107
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Ministry of Health, Sultanate of Oman | Oman Medical Specialty Board | Oman Ministry of Health

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Sickle Cell (Phase 3)

Asthma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3